4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-005724
CEO and CFO bought 600 shares at $16.53 ($9,918)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2023-02-17 | Purchase | +600 | $16.53 | $9,918 | 2,736,486 | D |
| Open-market purchases · 600 sh · avg $16.53 · $9,918 | |||||||
Loading xslF345X03/ownership.xml…